Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Inno Holdings | INHD | Mar 14, 2025 | 4.76 | -1.45 |
Innodata | INOD | Mar 14, 2025 | 48.18 | +11.68 |
Innospec | IOSP | Mar 14, 2025 | 98.09 | +1.33 |
InnovAge | INNV | Mar 14, 2025 | 3.22 | -0.31 |
Innovate | VATE | Mar 14, 2025 | 7.81 | +1.96 |
Innovation Beverage Group | IBG | Mar 14, 2025 | 0.47 | +2.41 |
Innovative Eyewear | LUCY | Mar 14, 2025 | 3.73 | -2.74 |
Innovative Industrial Properties | IIPR | Mar 14, 2025 | 69.62 | +2.08 |
Innovative Industrial Properties A Pref | IIPR-A | Mar 14, 2025 | 25.30 | +0.00 |
Innovative Solutions and Support | ISSC | Mar 14, 2025 | 6.66 | +3.74 |
Innovex International | INVX | Mar 14, 2025 | 17.74 | +2.31 |
Innovid | CTV | Mar 14, 2025 | 3.14 | 0.00 |
Innoviva | INVA | Mar 14, 2025 | 17.39 | 0.00 |
Innoviz Technologies | INVZ | Mar 14, 2025 | 0.65 | +3.40 |
InnSuites Hospitality | IHT | Mar 14, 2025 | 2.54 | -3.42 |
Innventure | INV | Mar 14, 2025 | 7.88 | -0.38 |
Inogen | INGN | Mar 14, 2025 | 7.45 | 0.00 |
Inotiv | NOTV | Mar 14, 2025 | 2.98 | +13.52 |
Inovio Pharmaceuticals | INO | Mar 14, 2025 | 2.03 | +5.18 |
Inozyme Pharma | INZY | Mar 14, 2025 | 1.00 | +0.03 |
InPoint Commercial Real Estate Pref A | ICR-A | Mar 14, 2025 | 19.47 | -3.02 |
Inseego | INSG | Mar 14, 2025 | 9.70 | +6.71 |
Insight Enterprises | NSIT | Mar 14, 2025 | 151.43 | +0.28 |
Insmed | INSM | Mar 14, 2025 | 76.55 | +1.97 |
Insperity | NSP | Mar 14, 2025 | 89.02 | +1.96 |
Inspira Technologies Oxy B.H.N. | IINN | Mar 14, 2025 | 0.73 | +4.27 |
Inspirato A | ISPO | Mar 14, 2025 | 3.90 | -2.50 |
Inspire Medical Systems | INSP | Mar 14, 2025 | 162.16 | +2.09 |
Inspire Tactical Balanced ESG ETF | RISN | Mar 14, 2025 | 25.97 | +1.57 |
Inspire Veterinary Partners | IVP | Mar 14, 2025 | 1.86 | +4.49 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.